Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 4, 2002, Pages 279-289

  Feuerstein, Michael ^a   Shaw, William S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Calendar of premenstrual experience; Medical research; Premenstrual syndrome; Survey methods

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ANALYSIS OF VARIANCE; APPETITE; ARTICLE; CALENDAR OF PREMENSTRUAL EXPERIENCE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG USE; FEMALE; FLUID RETENTION; HUMAN; LUTEAL PHASE; MATERNAL BEHAVIOR; MOOD; NORMAL HUMAN; PHYSICAL EXAMINATION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIFE CHANGE EVENTS; MEDICAL RECORDS; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0036238328     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. The shortened Premenstrual Assessment Form
2. Premenstrual and menstrual symptom clusters and response to calcium treatment
3. The premenstrual syndrome: A reappraisal of the concept and the evidence
4. Premenstrual syndrome: Documentation by a linear analog scale compared with two descriptive scales
5. Premenstrual syndrome in employed Chinese women in Hong Kong
6. Biological, social, and behavioral factors associated with premenstrual syndrome
7. Retrospective reports of premenstrual depressive changes: Factors affecting confirmation by daily ratings
8. Premenstrual changes: Patterns and correlates of daily ratings
9. Premenstrual syndrome: Weight, abdominal swelling, and perceived body image
10. Estrogen control of central neurotransmission: Effect on mood, mental state, and memory
11. Reliability and validity of a daily diary for premenstrual syndrome
12. Assessing premenstrual syndrome using the Premenstrual Experience Assessment
13. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form
14. Treatment of premenstrual dysphoria with alprazolam
15. Psychological aspects of premenstrual syndrome: I. Cognition and memory
16. The premenstrual syndrome
17. Premenstrual symptoms in Mexican women with different educational levels
18. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
19. Physical symptom cyclicity in women with and without the premenstrual syndrome
20. The development of the menstrual distress questionnaire
21. Issues in the diagnosis and research of premenstrual syndrome
22. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The Calendar of Premenstrual Experiences
23. Administration of the Hamilton Depression Rating Scale using interactive voice response technology
24. The premenstrual syndrome: A review
25. Fluoxetine in the treatment of premenstrual syndrome
26. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo
27. Validation of daily self-reported alcohol consumption using interactive voice response (IVR) technology
28. Prospective assessment of menstrually related mood disorders
29. Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales
30. Comparative analysis of three PMS assessment instruments: The identification of premenstrual syndrome with core symptoms
31. Premenstrual syndrome
32. Menstrual cycle symptom reporting in three British ethnic groups
33. The Structured Clinical Interview for DSM- III-R (SCID): II. Multisite test-retest reliability
34. Brain serotonin, carbohydratecraving, obesity and depression
35. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial: Sertraline Premenstrual Dysphoric Collaborative Study Group
36. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebocontrolled crossover trial
37. Assessment of premenstrual complaint using the Premenstrual Assessment Form: Comparison of two populations